Kestra Medical Technologies, Ltd. KMTS
NASDAQ
| 07/31/2026 | 04/30/2026 | 01/31/2026 | 10/31/2025 | 07/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -149.87M | -131.61M | -144.83M | -132.17M | -119.76M |
| Total Depreciation and Amortization | 9.35M | 8.71M | 8.22M | 8.13M | 7.62M |
| Total Amortization of Deferred Charges | 1.81M | 1.87M | 1.78M | 1.48M | 1.67M |
| Total Other Non-Cash Items | 50.74M | 37.55M | 52.74M | 43.32M | 34.83M |
| Change in Net Operating Assets | 254.00K | 1.78M | -4.94M | -7.42M | -10.74M |
| Cash from Operations | -87.72M | -81.70M | -87.04M | -86.67M | -86.38M |
| Capital Expenditure | -35.49M | -35.42M | -33.17M | -27.68M | -24.80M |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -180.91M | -167.86M | -4.80M | 173.00K | 297.00K |
| Cash from Investing | -216.40M | -203.28M | -37.98M | -27.51M | -24.51M |
| Total Debt Issued | 75.00M | -- | -- | -- | -- |
| Total Debt Repaid | -50.15M | -- | -- | -- | -- |
| Issuance of Common Stock | 152.32M | 149.88M | 367.45M | 218.16M | 218.16M |
| Repurchase of Common Stock | -1.01M | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | 0.00 | 0.00 | 0.00 |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -4.69M | -2.79M | -5.47M | -5.48M | -6.03M |
| Cash from Financing | 171.47M | 147.10M | 361.98M | 212.68M | 212.13M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -132.66M | -137.89M | 236.97M | 98.51M | 101.25M |